Shanghai Xuerong Bio-Technology (300511.SZ) is planning a change in company ownership and will continue to halt trading starting March 10th.

Shanghai Xuerong Bio-Technology (300511.SZ) Announcement: On March 5, 2025, the company received a notice from its controlling shareholder and actual controller Yang Yongping, who is planning the change of control of the company. It is expected that after the completion of this transaction, the counterparty will obtain the voting rights corresponding to 25.33% of the company's total share capital. The counterparty is a private enterprise in the technology service industry. Specific details will be subject to the relevant agreements signed by the parties. This transaction requires approval from relevant authorities. As of the disclosure date of this announcement, the parties involved are actively advancing the various work of this transaction, and the overall plan is still under negotiation. The company expects that trading will not resume from the morning of March 10, 2025 (Monday). Due to the significant uncertainty of the above matters, in order to ensure fair disclosure of information, protect the interests of investors, and avoid causing abnormal fluctuations in the company's stock price, according to the "Shenzhen Stock Exchange Stock Listing Rules" and other relevant regulations, the company has applied to the Shenzhen Stock Exchange. The company's shares (stock abbreviation: Shanghai Xuerong Bio-Technology, stock code: 300511) and convertible bonds (bond abbreviation: Xuerong Convertible Bonds, bond code: 123056) will continue to be suspended from trading from the morning of March 10, 2025 (Monday), and the suspension is expected to last for no more than 3 trading days.